Pregnancy, Mindfulness, and Massage

January 27, 2020 updated by: Yale University

Pregnancy Massage and Mindfulness Study for Tobacco Smoking Women

This trial will examine the contribution of massage therapy and mindfulness to tobacco-smoking women in the third trimester of pregnancy.

Study Overview

Status

Terminated

Detailed Description

Massage therapy may be a viable approach to decrease stress during pregnancy that may in turn reduce tobacco consumption. Massage therapy may not be sufficient as a stand-alone approach, and may be better suited partnered with a cessation approach that targets another mechanism of addiction, craving. Therefore, participants (N=60) will be enrolled in the Craving to Quit® tobacco cessation program, designed by researchers at Yale, which employs a mindfulness-based approach to train participants to recognize and bring cravings into their conscious awareness. Each mother will be randomly assigned to a bi-weekly massage intervention (n=30) or control (n=30) group. Participants in the intervention group will receive two prenatal massages a week for a three-week period.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Connecticut
      • New Haven, Connecticut, United States, 06520
        • Yale Child Study Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • currently pregnant in third trimester
  • singleton pregnancy
  • aged 18 years or older
  • women smoked before their pregnancy
  • women who currently smoke at least 5 cigarettes per day at enrollment
  • women need access to a smartphone
  • women expressing an interest in learning skills to help decrease tobacco-smoking

Exclusion Criteria:

  • incapable of giving informed consent
  • insufficient English fluency
  • participating in other smoking cessation programs
  • evidencing severe psychiatric symptoms

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Massage Therapy and Mindfulness
Participants in the intervention group will receive two prenatal massages a week for a three-week period. They will also be enrolled in the mindfulness-based Craving to Quit® tobacco cessation program during this 3-week period.
We will utilize moderate pressure Swedish massage (SM) that utilizes long slow strokes known as effleurage and kneading strokes known as petrissage. A specific routine will be performed on each participant with focus on low back, upper back, shoulders, and neck musculature. Consistent moderate pressure, which is lighter than deep tissue massage but deeper than brush strokes, will be used.
The intervention and control group will be enrolled in the Craving to Quit® program, a 21-day mindfulness-based program delivered via a smartphone application (https://www.cravingtoquit.com/). This program uses a mindfulness-based approach to train people to recognize and be aware of their tobacco cravings. The program includes videos, online exercises to complete, and a virtual support community.
Active Comparator: Mindfulness
Participants will enroll in the mindfulness-based Craving to Quit® tobacco cessation program during the same 3-week period. A massage will be provided upon completion of the study.
The intervention and control group will be enrolled in the Craving to Quit® program, a 21-day mindfulness-based program delivered via a smartphone application (https://www.cravingtoquit.com/). This program uses a mindfulness-based approach to train people to recognize and be aware of their tobacco cravings. The program includes videos, online exercises to complete, and a virtual support community.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tobacco Use Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
Number of cigarettes smoked in past 24 hours
Up to 4 weeks
Withdrawal Symptoms Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
Mood and Physical Symptoms Scale
Up to 4 weeks
Nicotine Dependence Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
FTND (Fagerstrom Test for Nicotine Dependence) measure
Up to 4 weeks
Depression Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
EPDS (Edinburgh Postnatal Depression Scale) measure
Up to 4 weeks
Anxiety Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
Beck Anxiety Inventory
Up to 4 weeks
Stress Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
Perceived Stress Scale
Up to 4 weeks
Daily Stress Scores Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
Diary Measure
Up to 4 weeks
Daily Tobacco Usage Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
Diary Measure
Up to 4 weeks
Heart Rate Variability Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
Maternal heart rate variability measured at rest
Up to 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neonatal Outcomes
Time Frame: Up to 2 months
mode of delivery (including any complications), infant well-being, gestational age, and weight.
Up to 2 months
Fetal Heart Rate Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
Fetal heart rate measured at rest
Up to 4 weeks
Engagement with Craving to Quit
Time Frame: Up to 4 weeks
Engagement with the Craving to Quit app
Up to 4 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
CO (carbon monoxide) monitoring Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
breath test
Up to 4 weeks
MINI (Mini International Neuropsychiatric Interview) Substance Dependence
Time Frame: Enrollment
determine other substance use disorders
Enrollment
Self-Reported Mood at each Massage Therapy Session for Intervention Group
Time Frame: Up to 3 weeks
positive and negative mood, including stress
Up to 3 weeks
Mind-mindedness related to infant
Time Frame: Up to 2 months
Describe your child measure; this will be a narrative statement provided by participants where they are asked to describe their child. These narratives will be scored to ascertain the total number of mind-minded comments included in the narrative.
Up to 2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Michael Paidas, MD, Yale University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 27, 2017

Primary Completion (Actual)

January 24, 2020

Study Completion (Actual)

January 24, 2020

Study Registration Dates

First Submitted

August 20, 2017

First Submitted That Met QC Criteria

September 6, 2017

First Posted (Actual)

September 8, 2017

Study Record Updates

Last Update Posted (Actual)

January 29, 2020

Last Update Submitted That Met QC Criteria

January 27, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2000021692

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tobacco Use

Clinical Trials on Prenatal Massage

3
Subscribe